Regulation
FDA clears Bright Uro’s abdominal sensor for evaluating bladder dysfunction
The FDA cleared Bright Uro's Glean abdominal sensor for evaluating bladder dysfunction. The sensor expands the capabilities of Bright Uro's Glean urodynamics system, which received FDA approval in March 2025. The abdominal sensor component enables non-invasive measurement of abdominal pressure during urodynamic testing.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network